<p>Prospective, Single-Center, Six-Month Study of Intravitreal Ranibizumab for Macular Edema with Nonproliferative Diabetic Retinopathy: Effects on Microaneurysm Turnover and Non-Perfused Retinal Area</p>
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.